Samalin Investment Counsel, LLC Eli Lilly & CO Transaction History

Samalin Investment Counsel, LLC

$222 Million
Q3 2024

A detailed history of Samalin Investment Counsel, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 2,807 shares of LLY stock, worth $2.28 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

2,807

Previous 3,031 7.39%

Holding current value

$2.28 Million

Previous $2.74 Million 9.4%

% of portfolio

1.12%

Previous 1.33%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $172,959 - $215,044	-224 Reduced 7.39%	2,807 $2.49 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $10,873 - $13,635	-15 Reduced 0.49%	3,031 $2.74 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $33,163 - $44,367	-56 Reduced 1.81%	3,046 $2.37 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $28,360 - $33,433	-54 Reduced 1.71%	3,102 $1.81 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $113,891 - $157,016	-262 Reduced 7.67%	3,156 $1.7 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $701 - $937	2 Added 0.06%	3,418 $1.6 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $12,735 - $14,957	-41 Reduced 1.19%	3,416 $1.17 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $54,985 - $64,068	-171 Reduced 4.71%	3,457 $1.26 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $50,105 - $57,100	-169 Reduced 4.45%	3,628 $1.17 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $113,443 - $133,198	407 Added 12.01%	3,797 $1.23 Million
Q1 2022 Oct 13, 2022	BUY	$234.69 - $291.66 $38,723 - $48,123	165 Added 5.12%	3,390 $971,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $38,723 - $48,123	165 Added 5.12%	3,390 $971 Million
Q4 2021 Oct 13, 2022	BUY	$224.85 - $279.04 $312,316 - $387,586	1,389 Added 75.65%	3,225 $891,000
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $312,316 - $387,586	1,389 Added 75.65%	3,225 $891 Million
Q3 2021 Oct 13, 2022	BUY	$221.6 - $272.71 $23,046 - $28,361	104 Added 6.0%	1,836 $424,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $23,046 - $28,361	104 Added 6.0%	1,836 $424 Million
Q2 2021 Oct 13, 2022	BUY	$180.55 - $233.54 $9,027 - $11,677	50 Added 2.97%	1,732 $398,000
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $8,216 - $10,636	50 Added 2.97%	1,732 $323,000
Q4 2020 Oct 13, 2022	SELL	$130.46 - $172.63 $74,362 - $98,399	-570 Reduced 25.31%	1,682 $284,000
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $74,362 - $98,399	-570 Reduced 25.31%	1,682 $284 Million
Q3 2020 Oct 13, 2022	SELL	$146.22 - $169.13 $225,909 - $261,305	-1,545 Reduced 40.69%	2,252 $333,000
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $8,480 - $9,809	-58 Reduced 2.51%	2,252 $333,000
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $68,482 - $82,418	-502 Reduced 17.85%	2,310 $379,000
Q1 2020 May 04, 2020	SELL	$119.05 - $147.35 $11,547 - $14,292	-97 Reduced 3.33%	2,812 $390,000
Q4 2019 Feb 05, 2020	BUY	$106.92 - $132.43 $311,030 - $385,238	2,909 New	2,909 $382,000

Others Institutions Holding LLY

# of Institutions

4,073

Shares Held

737M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Account

Samalin Investment Counsel, LLC Eli Lilly & CO Transaction History